- NYSDOH Statement on Mpox Name Change (12/1/22)
- WHO Recommends New Name for Monkeypox Disease (11/30/22)
- NYCDOHMH: Novavax COVID-19 Boosters Allowed for People Ages 18 Years and Older (11/1/22)
- NYCDOHMH: Considerations for Monkeypox and Pregnant, Recently Pregnant, and Breastfeeding Patients (10/19/22)
- NYCDOHMH: Bivalent COVID-19 Booster Recommendation Expanded to Include Children Ages 5 to 11 Years (10/15/22)
- New NYS Regulation: Minor Consent Allowed for Monkeypox Services (10/14/22)
- FDA Authorizes Moderna and Pfizer-BioNTech Bivalent COVID-19 Vaccines for Use as a Booster Dose in Younger Age Groups (10/12/2022)
- NYSDOH AI Dear Colleague Letter: COVID-19 Prevention & Treatment for Patients with HIV: Vaccines and Nirmatrelvir/Ritonavir (Paxlovid) (10/11/22)
- CDC: Severe Manifestations of Monkeypox among People who are Immunocompromised Due to HIV or Other Conditions (9/30/22)
- NYCDOHMH: Bivalent COVID-19 Boosters Recommended for Everyone Ages 12 Years and Older (9/17/22)